Calumet, Inc. /DE 8-K

What Happened Calumet, Inc. (CLMT) disclosed that two of its subsidiaries, Calumet Specialty Products Partners, L.P. and Calumet Finance Corp., issued $150.0 million aggregate principal amount of additional 9.75% Senior Notes due 2031 on March 17, 2026. The Additional Notes were sold in a private placement under Rule 144A and Regulation S at 105% of par (plus accrued interest from January 12, 2026) and were issued under the Indenture dated January 12, 2026. The company plans to use the net proceeds (approximately $154.9 million after fees and discounts) to repay borrowings under its revolving credit facility.

Key Details

• Amount: $150.0 million Additional Notes; they form a single series with $405.0 million of Existing Notes issued January 12, 2026 (total Notes outstanding now $555.0 million).
• Rate & Term: 9.75% coupon, maturity February 15, 2031; interest paid semi‑annually on Feb 15 and Aug 15 (first payment Aug 15, 2026).
• Price & Proceeds: Issued at 105% of par plus accrued interest; net proceeds ≈ $154.9 million after discounts and expenses.
• Security/Guarantees: Notes are senior unsecured and guaranteed by Calumet, Inc., Calumet GP, LLC, and substantially all of the Partnership’s subsidiaries (with limited specified exceptions).
• Placement: Private placement under Rule 144A and Regulation S; issued under the Indenture dated January 12, 2026.

Why It Matters This financing increases Calumet’s long‑term debt by $150 million while extending funding through 2031 at a fixed 9.75% rate. The stated use of proceeds—repaying the revolving credit facility—could reduce near‑term bank borrowings and affect liquidity and interest expense profile. Investors should note the total size of the 2031 note issuance (now $555 million) and that these are senior unsecured obligations guaranteed by the parent and most subsidiaries, which affects creditor priority but does not provide collateral.